159 related articles for article (PubMed ID: 37644601)
1. A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel.
Armstrong N; Olaye A; Noake C; Pang F
Orphanet J Rare Dis; 2023 Aug; 18(1):248. PubMed ID: 37644601
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
[TBL] [Abstract][Full Text] [Related]
3. Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatment.
Wu THY; Brown HA; Church HJ; Kershaw CJ; Hutton R; Egerton C; Cooper J; Tylee K; Cohen RN; Gokhale D; Ram D; Morton G; Henderson M; Bigger BW; Jones SA
Mol Genet Metab; 2024 May; 142(1):108349. PubMed ID: 38458124
[TBL] [Abstract][Full Text] [Related]
4. A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead.
Horgan C; Watts K; Ram D; Rust S; Hutton R; Jones S; Wynn R
JIMD Rep; 2023 Sep; 64(5):346-352. PubMed ID: 37701322
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
Boucher AA; Miller W; Shanley R; Ziegler R; Lund T; Raymond G; Orchard PJ
Orphanet J Rare Dis; 2015 Aug; 10():94. PubMed ID: 26245762
[TBL] [Abstract][Full Text] [Related]
6. Atidarsagene autotemcel for metachromatic leukodystrophy.
Messina M; Gissen P
Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy.
Cabanillas Stanchi KM; Böhringer J; Strölin M; Groeschel S; Lenglinger K; Treuner C; Kehrer C; Laugwitz L; Bevot A; Kaiser N; Schumm M; Lang P; Handgretinger R; Krägeloh-Mann I; Müller I; Döring M
Stem Cells Dev; 2022 Apr; 31(7-8):163-175. PubMed ID: 35323019
[TBL] [Abstract][Full Text] [Related]
10. Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy.
Eichler F; Sevin C; Barth M; Pang F; Howie K; Walz M; Wilds A; Calcagni C; Chanson C; Campbell L
Orphanet J Rare Dis; 2022 Oct; 17(1):370. PubMed ID: 36195888
[TBL] [Abstract][Full Text] [Related]
11. The burden of disease in metachromatic leukodystrophy: results of a caregiver survey in the UK and Republic of Ireland.
Thomas S; Morrison A; Morton G; Roberts P; Clark V; Imrie J
Orphanet J Rare Dis; 2024 Feb; 19(1):87. PubMed ID: 38403596
[TBL] [Abstract][Full Text] [Related]
12. Evaluating meaningful changes in physical functioning and cognitive declines in metachromatic leukodystrophy: a caregiver interview study.
Martin S; Harris N; Romanus D
J Patient Rep Outcomes; 2023 Jul; 7(1):70. PubMed ID: 37458805
[TBL] [Abstract][Full Text] [Related]
13. Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - Chances and challenges.
Santhanakumaran V; Groeschel S; Harzer K; Kehrer C; Elgün S; Beck-Wödl S; Hengel H; Schöls L; Haack TB; Krägeloh-Mann I; Laugwitz L
Mol Genet Metab; 2022 Nov; 137(3):273-282. PubMed ID: 36240581
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy.
Martin HR; Poe MD; Provenzale JM; Kurtzberg J; Mendizabal A; Escolar ML
Biol Blood Marrow Transplant; 2013 Apr; 19(4):616-24. PubMed ID: 23348427
[TBL] [Abstract][Full Text] [Related]
15. Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers.
Harrington M; Whalley D; Twiss J; Rushton R; Martin S; Huynh L; Yang H
Orphanet J Rare Dis; 2019 Apr; 14(1):89. PubMed ID: 31036045
[TBL] [Abstract][Full Text] [Related]
16. Chinese Cases of Metachromatic Leukodystrophy with the Novel Missense Mutations in ARSA Gene.
Wu S; Hou M; Zhang Y; Song J; Guo Y; Liu P; Liu Y; Yi L; Pan X; We W; Chen Z
J Mol Neurosci; 2021 Feb; 71(2):245-251. PubMed ID: 32617873
[TBL] [Abstract][Full Text] [Related]
17. Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy
St Martin T; Seabrook TA; Gall K; Newman J; Avila N; Hayes A; Kivaa M; Lotterhand J; Mercaldi M; Patel K; Rivas IJ; Woodcock S; Wright TL; Seymour AB; Francone OL; Gingras J
J Neurosci; 2023 May; 43(19):3567-3581. PubMed ID: 36977578
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.
Sevin C; Aubourg P; Cartier N
J Inherit Metab Dis; 2007 Apr; 30(2):175-83. PubMed ID: 17347913
[TBL] [Abstract][Full Text] [Related]
20. Toward Reference Intervals of ARSA Activity in the Cerebrospinal Fluid: Implication for the Clinical Practice of Metachromatic Leukodystrophy.
Morena F; Argentati C; Acquati S; DeWall S; Kelly F; Calbi V; Fumagalli F; Zancan S; Biffi A; Aiuti A; Martino S
J Appl Lab Med; 2021 Mar; 6(2):354-366. PubMed ID: 32910180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
